08.03.2010 • NewsWackerbiologicsproduction

Wacker Starts Up New Production Facility for Pharmaceutical Proteins

Wacker Chemie has opened a new production facility for pharmaceutical proteins - also known as biologics - in Jena, Germany. The new plant is part of the Munich-based chemical company's investment program to enlarge its biotech operations. The company said the expansion enables it to accommodate its customers' rapidly growing demand for biotechnologically manufactured pharmaceuticals. Biologics are used to treat, among other things, cancer, multiple sclerosis and hepatitis. The expansion, together with the new building for process development and quality control already completed last year, brings the company's total investment in the Jena facility to some €18 million.

Wacker said it has substantially boosted capacity at its Jena site in order to cope with a growing need for high-efficiency biologics production processes, and to meet rising customer demand. The existing GMP-certified (good manufacturing practice) facility now has twice as much production area. A completely new facility for product-purification enables up to three times higher product yields per batch. The new unit meets the GMP requirements of both the U.S. Food and Drug Administration FDA and the European Medicines Agency EMEA. Wacker Biotech can now provide those customers who have biopharmaceuticals at an advanced development stage with sufficient commercial capacity to supply the market.

Company

Universität Hohenheim - Institut für Lebensmitteltechnik

Garbenstrasse 25
70599 Stuttgart
Germany

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.